Biomea Fusion BMEA
NASDAQ BMEA
$0.58 -0.11 (-15.64%)
As of: Oct 22, 2026 · 3:59 PM EDT

Biomea Fusion (BMEA) Non Operating Investment Income (2026)

Updated

Biomea Fusion's Non Operating Investment Income came in at $510,000 for Q1 2026.

Analysis

Biomea Fusion (BMEA) Non Operating Investment Income (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Biomea Fusion 42.69 Mn -139.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 510,000.00
API Access

Biomea Fusion Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=BMEA&period=max&api_key=YOUR_API_KEY